Immune signatures in the blood may flag if someone has ovarian cancer up to four years earlier than conventional methods used to diagnose the disease, new research suggests.
Ovarian cancer is one of the deadliest cancers, with a five-year survival rate of less than 51%. Around 70% of ovarian cancer patients have high-grade ovarian cancer (HGOC), in which cancerous cells look particularly abnormal and are more likely to grow and spread than low-grade cancers.
